• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Cell Infect Microbiol . Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome

tetano

Editor, Senior Moderator
Front Cell Infect Microbiol


. 2022 Jan 24;11:781968.
doi: 10.3389/fcimb.2021.781968. eCollection 2021.
Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome


Meghan H Shilts[SUP] 1 [/SUP], Christian Rosas-Salazar[SUP] 2 [/SUP], Britton A Strickland[SUP] 1 3 [/SUP], Kyle S Kimura[SUP] 4 [/SUP], Mohammad Asad[SUP] 5 [/SUP], Esha Sehanobish[SUP] 5 [/SUP], Michael H Freeman[SUP] 4 [/SUP], Bronson C Wessinger[SUP] 3 4 [/SUP], Veerain Gupta[SUP] 3 4 [/SUP], Hunter M Brown[SUP] 1 [/SUP], Helen H Boone[SUP] 1 [/SUP], Viraj Patel[SUP] 5 [/SUP], Mali Barbi[SUP] 5 [/SUP], Danielle Bottalico[SUP] 5 [/SUP], Meaghan O'Neill[SUP] 5 [/SUP], Nadeem Akbar[SUP] 5 [/SUP], Seesandra V Rajagopala[SUP] 1 [/SUP], Simon Mallal[SUP] 1 [/SUP], Elizabeth Phillips[SUP] 1 [/SUP], Justin H Turner[SUP] 3 [/SUP], Elina Jerschow[SUP] 4 [/SUP], Suman R Das[SUP] 1 3 4 [/SUP]



Affiliations

Abstract

Background: The upper respiratory tract (URT) is the portal of entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and SARS-CoV-2 likely interacts with the URT microbiome. However, understanding of the associations between the URT microbiome and the severity of coronavirus disease 2019 (COVID-19) is still limited.
Objective: Our primary objective was to identify URT microbiome signature/s that consistently changed over a spectrum of COVID-19 severity.
Methods: Using data from 103 adult participants from two cities in the United States, we compared the bacterial load and the URT microbiome between five groups: 20 asymptomatic SARS-CoV-2-negative participants, 27 participants with mild COVID-19, 28 participants with moderate COVID-19, 15 hospitalized patients with severe COVID-19, and 13 hospitalized patients in the ICU with very severe COVID-19.
Results: URT bacterial load, bacterial richness, and within-group microbiome composition dissimilarity consistently increased as COVID-19 severity increased, while the relative abundance of an amplicon sequence variant (ASV), Corynebacterium_unclassified.ASV0002, consistently decreased as COVID-19 severity increased.
Conclusions: We observed that the URT microbiome composition significantly changed as COVID-19 severity increased. The URT microbiome could potentially predict which patients may be more likely to progress to severe disease or be modified to decrease severity. However, further research in additional longitudinal cohorts is needed to better understand how the microbiome affects COVID-19 severity.

Keywords: COVID-19; SARS-CoV-2; microbiome; mild; moderate; severe COVID-19 outcomes; upper respiratory tract.
 
Back
Top Bottom